RENVELA
RENVELA
Approved
DIN Number
02354586
Drug Class
Human
Market Date
Nov 25, 2010
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02354586
AIG Number0152763001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AE02 SEVELAMER
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:18.19
Health Canada Classification
ACTIVE INGREDIENTS (1)
SEVELAMER CARBONATEActive
Strength: 800 MG
Monograph: SEVELAMER CARBONATE